04/19/2024
3:14 PM | Sangamo Therapeutics (Filer)
| Form ARS | |
03/25/2024
4:04 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
6:55 AM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
6:47 AM | Sangamo Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
6:11 PM | BIOGEN INC. (Filed by)
Sangamo Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
11:17 AM | Sangamo Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/06/2024
3:35 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/24/2024
3:40 PM | Dubois-Stringfellow Nathalie (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:41 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:42 PM | Sangamo Therapeutics (Issuer)
Willoughby Scott B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:42 PM | Pooler Amy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:39 PM | Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
11:18 AM | Sangamo Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/19/2024
4:09 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2023
6:55 AM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
3:15 PM | Pooler Amy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:16 PM | Dubois-Stringfellow Nathalie (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:17 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:18 PM | Fontenot Jason D. (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:19 PM | Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:19 PM | McClung David Mark (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:20 PM | Sangamo Therapeutics (Issuer)
Willoughby Scott B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
2:09 PM | Sangamo Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
09/28/2023
4:30 PM | BIOGEN INC. (Reporting)
Biogen MA Inc. (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
3:12 PM | Sangamo Therapeutics (Issuer)
Willoughby Scott B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
3:13 PM | Dubois-Stringfellow Nathalie (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
3:13 PM | Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
3:14 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
3:15 PM | McClung David Mark (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
3:15 PM | Fontenot Jason D. (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
3:55 PM | Sangamo Therapeutics (Issuer)
Willoughby Scott B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:31 PM | McClung David Mark (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:52 PM | Sangamo Therapeutics (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:46 PM | Beers Courtney (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:47 PM | Carey Robert (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:48 PM | Hillan Kenneth J. (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:48 PM | Horn Margaret A (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:49 PM | Markels John (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:50 PM | Meyers James R (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:51 PM | PARKER H STEWART (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:40 PM | Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
#1 election stock (Ad) I’ve found the number one company to buy…
Before either Trump or Biden wins in November.
It all has to do with an overlooked executive order that Trump signed just days before leaving office… and that Biden has quietly hijacked for his own political power.  For the full story, click here. |
05/30/2023
3:41 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:42 PM | Fontenot Jason D. (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:43 PM | Dubois-Stringfellow Nathalie (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:43 PM | McClung David Mark (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:44 PM | Ramelmeier Rolf Andrew (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:45 PM | Sangamo Therapeutics (Issuer)
Willoughby Scott B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
